Shanghai, China

Fang Liu

This inventor holds 64 USPTO granted patents and 41 published patent applications and 22 EPO patents, primarily in Pharmaceutical Development (CPC class C07D). Top assignees: Agios Pharmaceuticals, Inc., Medshine Discovery Inc., Shanghai Tianma Am-Oled Co., Ltd.. Active years: 2008-2026.

USPTO Granted Patents = 64 

% Patents Active = 85.9

 

Average Co-Inventor Count = 4.5

ph-index = 8

Forward Citations = 271(Granted Patents)

Forward Citations (Not Self Cited) = 254(Dec 10, 2025)


Inventors with similar research interests:


Company Filing History:

goldMedal5 out of 99 
 
Agios Pharmaceuticals, Inc.
 patents
silverMedal5 out of 72 
 
Medshine Discovery Inc.
 patents
bronzeMedal5 out of 351 
 
Shanghai Tianma Am-Oled Co., Ltd.
 patents
4. 5 out of 680 
 
Tianma Micro-Electronics Co., Ltd.
 patents
5. 4 out of 1,430 
 
Finisar Corporation
 patents
6. 4 out of 52,347 
 
General Electric Company
 patents
7. 3 out of 8 
 
Abelzeta Inc.
 patents
8. 3 out of 13 
 
Guangdong Raynovent Biotech Co., Ltd.
 patents
9. 3 out of 3 
 
Shanghai Abelzeta Ltd.
 patents
10. 2 out of 224 
 
Fudan University
 patents
11. 2 out of 21,862 
 
Koninklijke Philips Corporation N.v.
 patents
12. 2 out of 2,396 
 
Lear Corporation
 patents
13. 2 out of 603 
 
Micro Focus Lcc
 patents
14. 2 out of 887 
 
Shanghai United Imaging Healthcare Co., Ltd.
 patents
15. 2 out of 1,974 
 
Via Technologies, Inc.
 patents
16. 1 out of 4,054 
 
Carrier Corporation
 patents
17. 1 out of 8 
 
Cellular Biomedicine Group Hk Limited
 patents
18. 1 out of 5 
 
Cellular Biomedicine Group, Inc.
 patents
19. 1 out of 2 
 
China Resources Pharmaceutical Holdings Company Limited
 patents
20. 1 out of 21,321 
 
Cisco Technology, Inc.
 patents
21. 1 out of 1 
 
Cstone Pharmaceutical (Suzhou) Co., Ltd.
 patent
22. 1 out of 9 
 
Cstone Pharmaceuticals
 patents
23. 1 out of 1 
 
Cstone Pharmaceuticals (Shanghai) Co., Ltd.
 patent
24. 1 out of 3 
 
Finisar Shanghai Incorporation
 patents
25. 1 out of 5 
 
Guangdong Zhongsheng Pharmaceutical Co., Ltd
 patents
26. 1 out of 3 
 
Guangzhou Joyo Pharmatech Co., Ltd
 patents
27. 1 out of 4 
 
Guangzhou Joyo Pharmatech Co., Ltd.
 patents
28. 1 out of 408 
 
Ii-Vi Delaware, Inc.
 patents
29. 1 out of 1 
 
Il-Vi Delaware, Inc.
 patent
30. 1 out of 40 
 
Merck Canada Inc.
 patents
31. 1 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
32. 1 out of 5,315 
 
Nxp B.v.
 patents
33. 1 out of 22 
 
Servier Pharmaceuticals LLC
 patents
34. 1 out of 2 
 
Shanghai Cellular Biopharmaceutical Group Ltd.
 patents
35. 1 out of 42 
 
Shanghai Institute of Pharmaceutical Industry
 patents
36. 1 out of 1,428 
 
Volvo Car Corporation
 patents
37. 2 out of 834,350 
Other
 patents
where one patent can have more than one assignee

Years Active: 2008-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Lentiviral Vector
HER2 Inhibitors
Pharmaceutical Compounds
Optical Design
Wireless Communication
PCR Detection
Power Management
Recombinant Technology
Chimeric Antigen Receptor
Synchronous Rectifier
Crystal Form
Bidirectional Module
64 patents (USPTO):Explore Patents

Certainly! Here is an article about the accomplished inventor Fang Liu:

Title: Innovator Spotlight: Fang Liu - Pioneering Inventions in Shanghai

Introduction:

Fang Liu, a visionary inventor based in Shanghai, CN, has made significant contributions to the field of biotechnology and mobile semantic segmentation. With an impressive portfolio of 50 patents, Liu's groundbreaking work has redefined standards in large-scale production techniques and transformative technologies.

Latest Patents:

Liu's latest patents showcase her innovative prowess. One of her notable inventions is the "Method for large-scale production of lentivirus by using GMP-level serum-free suspension cells." This method revolutionizes the production process by utilizing serum-free cell culture solutions, ensuring efficiency and quality in the production of lentivirus.

Another cutting-edge invention by Liu is the "Squeeze-enhanced axial transformer" (SeaFormer) for mobile semantic segmentation. This transformative technology integrates shared stem, context branch, spatial branch, fusion module, and light segmentation head to enhance semantic segmentation capabilities for mobile applications.

Career Highlights:

Throughout her career, Liu has worked with esteemed companies such as Agios Pharmaceuticals, Inc. and Shanghai Tianma AM-OLED Co., Ltd. Her innovative spirit and dedication to pushing boundaries have not only influenced her work but have also inspired her colleagues and peers in the industry.

Collaborations:

Collaborating with talented individuals is crucial in the world of innovation. Some of Liu's notable coworkers include Lingyun Wu and Shuhui Chen. Together, they have synergized their expertise to bring forth groundbreaking solutions in their respective fields.

Conclusion:

In conclusion, Fang Liu's inventive genius and relentless pursuit of excellence have propelled her to the forefront of the innovation landscape. Her impactful patents and collaborations stand as a testament to her ingenuity and unwavering commitment to advancing technology. Liu's contributions continue to shape the future of biotechnology and mobile semantic segmentation, leaving a lasting imprint on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…